Literature DB >> 28620593

Phenotypic and Molecular Identification of Nocardia in Brain Abscess.

Mehdi Fatahi-Bafghi1.   

Abstract

Entities:  

Year:  2017        PMID: 28620593      PMCID: PMC5433655          DOI: 10.4103/2277-9175.205191

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


× No keyword cloud information.
Sir, Shirani et al. recently reported an article entitled, “Nocardial brain abscess in a patient with pulmonary alveolar proteinosis” (DOI: 10.4103/2277-9175.164004).[1] The genus Nocardia is a Gram-positive aerobic, partially acid-fast, and filamentous bacterium that causes nocardial infections (nocardiosis) in human. The genus Nocardia is normal microflora in the environment such as soil and dust.[2] Nocardiosis treatment is different in various species, and some species are resistant to different antibiotics such as trimethoprim-sulfamethoxazole, carbapenem, and aminoglycosides, as well as accurate identification in species level is important. Attention to comments and questions: Isolation and characterization of morphology of colony, aerial hyphae, Gram stain, partially acid-fast, acid-fast, growth in lysozyme broth and molecular methods are important for the genus Nocardia confirmation.[234] Moreover, other aerobic actinomycetes such as Gordonia spp., Rhodococcus spp., and Tsukamurella spp. are Gram-positive, may be filamentous and colonial morphology are similar to each other. Gordonia spp., Rhodococcus spp., Tsukamurella spp., and Nocardia spp. are acid-fast in under certain conditions (bacteria listed are partially acid-fast and normally are not positive for acid-fast staining)[23456789101112] while authors suggested that branching, filamentous, Gram-positive, and acid-fast positive elements are the genus Nocardia Authors reported Nocardia asteroides identification with culture and staining.[1] Phenotypic methods such as hydrolysis of amino acids, production of nitrate reductase, gelatinase, and urease, producing acid from carbohydrates, and growth at 45°C[2] are used in species level identification. I have two questions for authors: The genus Nocardia has some of complex groups such as N. asteroides complex (N. asteroides, Nocardia cyriacigeorgica, Nocardia farcinica, etc.,) and Nocardia nova complex.[2] Authors explain that how identified N. asteroides of other species in N. asteroides complex? The authors have not mentioned of the use of molecular techniques to Nocardia identification at species level in the article. The authors explain molecular method if used. In literature, although phenotypic methods are labor intensive and time-consuming, they are used in combination with molecular techniques such as polymerase chain reaction (PCR) sequencing (16S rRNA, hsp65, rpoB, gyrB, and secA genes) and PCR-restriction fragment length polymorphism for accurate identification in genus and species levels for Nocardia[213] Drug choice for nocardiosis treatment is co-trimoxazole, but some of species are resistance to co-trimoxazole and other antibacterial agents; therefore, accurate identification in species level and antimicrobial susceptibility testing are important.[214] Further, in literature, some of patients have hypersensitive reaction to co-trimoxazole.[15]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  14 in total

1.  Gordonia terrae: a difficult-to-diagnose emerging pathogen?

Authors:  V Blanc; M Dalle; A Markarian; M V Debunne; E Duplay; V Rodriguez-Nava; P Boiron
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

2.  Clinical characteristics of infections caused by Tsukamurella spp. and antimicrobial susceptibilities of the isolates.

Authors:  Chia-Ying Liu; Chih-Cheng Lai; Meng-Rui Lee; Yi-Chieh Lee; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2011-10-19       Impact factor: 5.283

3.  The actinomycete-genus Rhodococcus: a home for the "rhodochrous" complex.

Authors:  M Goodfellow; G Alderson
Journal:  J Gen Microbiol       Date:  1977-05

4.  Characterisation of Mycobacterium, Nocardia, Corynebacterium and related taxa.

Authors:  M Goodfellow
Journal:  Ann Soc Belg Med Trop       Date:  1973

5.  A co-operative numerical analysis of cultures considered to belong to the 'rhodochrous' taxon.

Authors:  M Goodfellow; A Lind; H Mordarska; S Pattyn; M Tsukamura
Journal:  J Gen Microbiol       Date:  1974-12

Review 6.  Rhodococcus equi: an animal and human pathogen.

Authors:  J F Prescott
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Phylogeny and identification of Nocardia species on the basis of multilocus sequence analysis.

Authors:  L R McTaggart; S E Richardson; M Witkowska; S X Zhang
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.

Authors:  Barbara A Brown-Elliott; Jon Biehle; Patricia S Conville; Samuel Cohen; Michael Saubolle; Den Sussland; Nancy Wengenack; Kimberly Kriel; Linda Bridge; Steven McNulty; Ravikiran Vasireddy; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

9.  Actinomycetoma caused by Rhodococcus spp.

Authors:  L C Severo; V F Petrillo; L M Coutinho
Journal:  Mycopathologia       Date:  1987-06       Impact factor: 2.574

10.  Nocardial brain abscess in a patient with pulmonary alveolar proteinosis.

Authors:  Kiana Shirani; Asger Nyborg Poulsen; Atousa Hakamifard
Journal:  Adv Biomed Res       Date:  2015-08-31
View more
  2 in total

1.  Evaluation of Polymerase Chain Reaction for Detecting Coliform Bacteria in Drinking Water Sources.

Authors:  Bahram Nasr Isfahani; Hossein Fazeli; Zeinab Babaie; Farkhondeh Poursina; Sharareh Moghim; Meisam Rouzbahani
Journal:  Adv Biomed Res       Date:  2017-10-16

2.  Comments on: Phenotypic and Molecular Identification of Nocardia in Brain Abscess.

Authors:  Kiana Shirani; Atousa Hakamifard; Asger Nyborg Poulsen
Journal:  Adv Biomed Res       Date:  2017-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.